AAAAAA

   
Results: 1-20 |
Results: 20
S100 PROTEIN SERUM LEVELS IN CUTANEOUS MALIGNANT-MELANOMA
Authors: SEREGNI E MASSARON S MARTINETTI A ILLENI MT ROVINI D BELLI F AGRESTI R GRECO M CASCINELLI N BOMBARDIERI E
Citation: E. Seregni et al., S100 PROTEIN SERUM LEVELS IN CUTANEOUS MALIGNANT-MELANOMA, Oncology Reports, 5(3), 1998, pp. 601-604
NEURON-SPECIFIC ENOLASE EVALUATION IN PATIENTS WITH NEUROBLASTOMA
Authors: MASSARON S SEREGNI E LUKSCH R CASANOVA M BOTTI C FERRARI L MARTINETTI A MOLTENI SN BELLANI FF BOMBARDIERI E
Citation: S. Massaron et al., NEURON-SPECIFIC ENOLASE EVALUATION IN PATIENTS WITH NEUROBLASTOMA, Tumor biology, 19(4), 1998, pp. 261-268
BONE METABOLISM MARKERS IN PREMENOPAUSAL BREAST-CANCER PATIENTS TREATED WITH THE LHRH ANALOG TRIPTORELIN ALONE OR IN COMBINATION WITH THE AROMATASE INHIBITOR FORMESTANE
Authors: MARTINETTI A CELIO L FERRARI L ZILEMBO N MARIANI L SEREGNI E BOMBARDIERI E GALANTE E STANI S BAJETTA E
Citation: A. Martinetti et al., BONE METABOLISM MARKERS IN PREMENOPAUSAL BREAST-CANCER PATIENTS TREATED WITH THE LHRH ANALOG TRIPTORELIN ALONE OR IN COMBINATION WITH THE AROMATASE INHIBITOR FORMESTANE, Annals of oncology, 9, 1998, pp. 87-87
THE COMBINATION OF AN LH-RH ANALOG AND AN AROMATASE INHIBITOR (AL) INPREMENOPAUSAL BREAST-CANCER - INFLUENCE ON THE INSULIN-LIKE-GROWTH-FACTOR (IGF) SYSTEM AND THE INTERLEUKIN (IL)-6
Authors: FERRARI L MARTINETTI A CELIO L BUZZONI R MARIANI L SEREGNI E BOMBARDIERI E POZZI P PROCOPIO G BAJETTA E
Citation: L. Ferrari et al., THE COMBINATION OF AN LH-RH ANALOG AND AN AROMATASE INHIBITOR (AL) INPREMENOPAUSAL BREAST-CANCER - INFLUENCE ON THE INSULIN-LIKE-GROWTH-FACTOR (IGF) SYSTEM AND THE INTERLEUKIN (IL)-6, Annals of oncology, 9, 1998, pp. 126-126
EVALUATION ON SERUM 2'-5' OLIGOADENYLATE SYNTHETASE (2'-5' OLIGOAS) AND BETA-2-MICROGLOBULIN (B2M) IN PATIENTS WITH NODAL METASTASES FROM CUTANEOUS MALIGNANT-MELANOMA TREATED WITH RIFN-ALPHA-2A
Authors: MARTINETTI A SEREGNI E BELLI F MAZZOCCHI A AGRESTI R CASCINELLI N GRECO M BOMBARDIERI E
Citation: A. Martinetti et al., EVALUATION ON SERUM 2'-5' OLIGOADENYLATE SYNTHETASE (2'-5' OLIGOAS) AND BETA-2-MICROGLOBULIN (B2M) IN PATIENTS WITH NODAL METASTASES FROM CUTANEOUS MALIGNANT-MELANOMA TREATED WITH RIFN-ALPHA-2A, Anticancer research, 18(3B), 1998, pp. 2027-2030
EFFECTS OF AROMATASE COMPLEX SELECTIVE-INHIBITION ON INSULIN-LIKE-GROWTH-FACTOR-1 AND INSULIN-LIKE-GROWTH-FACTOR BINDING-PROTEIN-3 CIRCULATING LEVELS IN BREAST-CANCER
Authors: FERRARI L BAJETTA E SEREGNI E MARTINETTI A ZILEMBO N NOBERASCO C BUZZONI R BOTTI C MASSARON S BICHISAO E CELIO L BOMBARDIERI E
Citation: L. Ferrari et al., EFFECTS OF AROMATASE COMPLEX SELECTIVE-INHIBITION ON INSULIN-LIKE-GROWTH-FACTOR-1 AND INSULIN-LIKE-GROWTH-FACTOR BINDING-PROTEIN-3 CIRCULATING LEVELS IN BREAST-CANCER, International journal of oncology, 11(1), 1997, pp. 163-167
SERUM MARKERS OF BONE METASTASES IN POSTMENOPAUSAL BREAST-CANCER PATIENTS TREATED WITH FORMESTANE
Authors: MARTINETTI A BAJETTA E SEREGNI E ZILEMBO N FERRARI L NOBERASCO C MASSARON S RIMASSA L BOMBARDIERI E
Citation: A. Martinetti et al., SERUM MARKERS OF BONE METASTASES IN POSTMENOPAUSAL BREAST-CANCER PATIENTS TREATED WITH FORMESTANE, Tumor biology, 18(4), 1997, pp. 197-205
THE AROMATASE INHIBITOR LETROZOLE IN ADVANCED BREAST-CANCER - EFFECTSON SERUM-INSULIN LIKE GROWTH-FACTOR (IGF)-I AND IGF BINDING PROTEIN-3LEVELS
Authors: BAJETTA E FERRARI L CELIO L MARIANI L MICELI R DILEO A ZILEMBO N BUZZONI R SPAGNOLI I MARTINETTI A BICHISAO E SEREGNI E
Citation: E. Bajetta et al., THE AROMATASE INHIBITOR LETROZOLE IN ADVANCED BREAST-CANCER - EFFECTSON SERUM-INSULIN LIKE GROWTH-FACTOR (IGF)-I AND IGF BINDING PROTEIN-3LEVELS, Journal of steroid biochemistry and molecular biology, 63(4-6), 1997, pp. 261-267
THE LHRH ANALOG TRIPTORELINE (TRP) WITH OR WITHOUT THE AROMATASE INHIBITOR FORMESTANE (4-OHA) IN PREMENOPAUSAL ADVANCED BREAST-CANCER - A STUDY BY THE ITMO GROUP
Authors: CELIO L MARTINETTI A FERRARI L BUZZONI R BOMBARDIERI E ZILEMBO N MAIORINO L BAJETTA E
Citation: L. Celio et al., THE LHRH ANALOG TRIPTORELINE (TRP) WITH OR WITHOUT THE AROMATASE INHIBITOR FORMESTANE (4-OHA) IN PREMENOPAUSAL ADVANCED BREAST-CANCER - A STUDY BY THE ITMO GROUP, European journal of cancer, 33, 1997, pp. 691-691
THE MINIMAL EFFECTIVE EXEMESTANE DOSE FOR ENDOCRINE ACTIVITY IN ADVANCED BREAST-CANCER
Authors: BAJETTA E ZILEMBO N NOBERASCO C MARTINETTI A MARIANI L FERRARI L BUZZONI R GRECO M BARTOLI C SPAGNOLI I DANESINI GM ARTALE S PAOLINI J
Citation: E. Bajetta et al., THE MINIMAL EFFECTIVE EXEMESTANE DOSE FOR ENDOCRINE ACTIVITY IN ADVANCED BREAST-CANCER, European journal of cancer, 33(4), 1997, pp. 587-591
A MULTICENTER, RANDOMIZED, PHARMACOKINETIC, ENDOCRINE AND CLINICAL-STUDY TO EVALUATE FORMESTANE IN BREAST-CANCER PATIENTS AT FIRST RELAPSE - ENDOCRINE AND CLINICAL-RESULTS
Authors: BAJETTA E ZILEMBO N BARNI S NOBERASCO C MARTINETTI A FERRARI L SCHIEPATTI G BUZZONI R JIRILLO A AMICHETTI M DAPRILE M COMELLA G BICHISAO E BOLELLI GF ATTILI A BOMBARDIERI E
Citation: E. Bajetta et al., A MULTICENTER, RANDOMIZED, PHARMACOKINETIC, ENDOCRINE AND CLINICAL-STUDY TO EVALUATE FORMESTANE IN BREAST-CANCER PATIENTS AT FIRST RELAPSE - ENDOCRINE AND CLINICAL-RESULTS, Annals of oncology, 8(7), 1997, pp. 649-654
CAN BONE METABOLISM MARKERS BE ADOPTED AS AN ALTERNATIVE TO SCINTIGRAPHIC IMAGING IN MONITORING BONE METASTASES FROM BREAST-CANCER
Authors: BOMBARDIERI E MARTINETTI A MICELI R MARIANI L CASTELLANI MR SEREGNI E
Citation: E. Bombardieri et al., CAN BONE METABOLISM MARKERS BE ADOPTED AS AN ALTERNATIVE TO SCINTIGRAPHIC IMAGING IN MONITORING BONE METASTASES FROM BREAST-CANCER, European journal of nuclear medicine, 24(11), 1997, pp. 1349-1355
MUCINOUS MARKERS IN BREAST-CANCER
Authors: SEREGNI E BOTTI C MASSARON S MARTINETTI A FERRARI L MOLTENI SN BOMBARDIERI E
Citation: E. Seregni et al., MUCINOUS MARKERS IN BREAST-CANCER, Tumori, 83(2), 1997, pp. 550-551
TESTOSTERONE, DIHYDROTESTOSTERONE AND ESTRADIOL LEVELS IN POSTMENOPAUSAL BREAST-CANCER TISSUES
Authors: RECCHIONE C VENTURELLI E MANZARI A CAVALLERI A MARTINETTI A SECRETO G
Citation: C. Recchione et al., TESTOSTERONE, DIHYDROTESTOSTERONE AND ESTRADIOL LEVELS IN POSTMENOPAUSAL BREAST-CANCER TISSUES, Journal of steroid biochemistry and molecular biology, 52(6), 1995, pp. 541-546
EXEMESTANE IN POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER - ADOSE-FINDING STUDY
Authors: ZILEMBO N NOBERASCO C MARTINETTI A MARIANI L RIMASSA L DELVECCHIO M LAFFRANCHI A OREFICE S GALANTE E SGUOTTI C BAJETTA E
Citation: N. Zilembo et al., EXEMESTANE IN POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER - ADOSE-FINDING STUDY, European journal of cancer, 31A, 1995, pp. 963-963
ENDOCRINOLOGIC AND CLINICAL-EVALUATION OF EXEMESTANE, A NEW STEROIDALAROMATASE INHIBITOR
Authors: ZILEMBO N NOBERASCO C BAJETTA E MARTINETTI A MARIANI L OREFICE S BUZZONI R DIBARTOLOMEO M DILEO A LAFFRANCHI A DISALLE E
Citation: N. Zilembo et al., ENDOCRINOLOGIC AND CLINICAL-EVALUATION OF EXEMESTANE, A NEW STEROIDALAROMATASE INHIBITOR, British Journal of Cancer, 72(4), 1995, pp. 1007-1012
COMBINATION GOSERELIN AND TAMOXIFEN THERAPY IN PREMENOPAUSAL ADVANCEDBREAST-CANCER - A MULTICENTER STUDY BY THE ITMO GROUP
Authors: BUZZONI R BIGANZOLI L BAJETTA E CELIO L FORNASIERO A MARIANI L ZILEMBO N BARTOLOMEO MD LEO AD ARCANGELI G AITINI E FARINA G SCHIEPPATI G GALLUZZO D MARTINETTI A
Citation: R. Buzzoni et al., COMBINATION GOSERELIN AND TAMOXIFEN THERAPY IN PREMENOPAUSAL ADVANCEDBREAST-CANCER - A MULTICENTER STUDY BY THE ITMO GROUP, British Journal of Cancer, 71(5), 1995, pp. 1111-1114
EFFECT OF 2 4-HYDROXYANDROSTENEDIONE DOSES ON SERUM INSULIN-LIKE GROWTH-FACTOR-I LEVELS IN ADVANCED BREAST-CANCER
Authors: FERRARI L ZILEMBO N BAJETTA E BUZZONI R NOBERASCO C MARTINETTI A CELIO L GALANTE E OREFICE S CERROTTA AM
Citation: L. Ferrari et al., EFFECT OF 2 4-HYDROXYANDROSTENEDIONE DOSES ON SERUM INSULIN-LIKE GROWTH-FACTOR-I LEVELS IN ADVANCED BREAST-CANCER, Breast cancer research and treatment, 30(2), 1994, pp. 127-132
GOSERELIN IN PREMENOPAUSAL ADVANCED BREAST-CANCER - CLINICAL AND ENDOCRINE EVALUATION OF RESPONSIVE PATIENTS
Authors: BAJETTA E ZILEMBO N BUZZONI R CELIO L ZAMPINO MG COLLEONI M ORIANA S ATTILI A SACCHINI V MARTINETTI A
Citation: E. Bajetta et al., GOSERELIN IN PREMENOPAUSAL ADVANCED BREAST-CANCER - CLINICAL AND ENDOCRINE EVALUATION OF RESPONSIVE PATIENTS, Oncology, 51(3), 1994, pp. 262-269
URINARY TESTOSTERONE AS A MARKER OF RISK OF RECURRENCE IN OPERABLE BREAST-CANCER
Authors: BALLERINI P ORIANA S DUCA P MARTINETTI A VENTURELLI E FERRARI L DOLCI S SECRETO G
Citation: P. Ballerini et al., URINARY TESTOSTERONE AS A MARKER OF RISK OF RECURRENCE IN OPERABLE BREAST-CANCER, Breast cancer research and treatment, 26(1), 1993, pp. 1-6
Risultati: 1-20 |